UPCOMING DEADLINE: Levi & Korsinsky Notifies Investors with Losses on Their Investment in Vanda Pharmaceuticals, Inc. of Clas...
13 8월 2013 - 6:00AM
Business Wire
Levi & Korsinsky announces that a class action lawsuit has
been commenced in the United States District Court for the District
of Columbia on behalf of investors who purchased Vanda
Pharmaceuticals, Inc. (“Vanda” or the “Company”) (NasdaqGM: VNDA)
stock between December 18, 2012 and June 18, 2013.
For more information, click here:
http://zlk.9nl.com/vanda-pharmaceuticals-vnda/.
The complaint alleges that defendants violated federal
securities laws by issuing materially false and misleading
statements and/or failing to disclose materially adverse facts
concerning the Company’s Phase III testing of the drug Tasimelteon.
In particular, it is alleged that, in the middle of the Phase III
studies, Vanda altered the primary endpoint to one never before
used in a sleep-drug clinical trial—and not endorsed by the
FDA—when data suggested the original endpoint would not be met.
On June 19, 2013, an article was published on thestreet.com,
questioning the efficacy of Vanda’s study, noting that the study
not only changed multiple times, but that it replaced the primary
endpoint just a month before study results were announced. On the
news, shares of Vanda closed at $8.51 per share on June 19, 2013, a
drop of more than 20% from the previous day.
If you suffered a loss in Vanda you have until August 26, 2013
to request that the Court appoint you as lead plaintiff. Your
ability to share in any recovery doesn’t require that you serve as
a lead plaintiff. To obtain additional information, contact Joseph
E. Levi, Esq. either via email at jlevi@zlk.com or by telephone at
(877) 363-5972, or visit
http://zlk.9nl.com/vanda-pharmaceuticals-vnda/.
Levi & Korsinsky is a national firm with offices in New
York, New Jersey, and Washington D.C. The firm has extensive
expertise in prosecuting securities litigation involving financial
fraud, representing investors throughout the nation in securities
and shareholder lawsuits. Attorney advertising. Prior results do
not guarantee similar outcomes.
Levi & Korsinsky, LLPJoseph Levi, Esq.Eduard Korsinsky,
Esq.Tel: 212-363-7500Toll Free: 877-363-5972Fax:
866-367-6510www.zlk.com
Vanda Pharmaceuticals (NASDAQ:VNDA)
과거 데이터 주식 차트
부터 6월(6) 2024 으로 7월(7) 2024
Vanda Pharmaceuticals (NASDAQ:VNDA)
과거 데이터 주식 차트
부터 7월(7) 2023 으로 7월(7) 2024